Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds
Covid-19 Research Scandal: Medical Journal Lancet Retracts Study That Halted Trials Of Anti-Malarial Drug HCQ
New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers Infection Risk For Healthcare Workers
Medical Journal Issues Correction On Study That Led WHO To Pause Trial Of Anti-Malarial Drug HCQ On Covid-19 Patients
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?
Trial Of Anti-Malarial Drug Hydroxychloroquine As Prophylactic Against Covid-19 Begins In UK
A New Study Unveiled By Prominent French Virologist Claims HCQ-AZ Combination Removed Novel Coronavirus In 92 Per Cent Cases
After Relaxing Export Ban, India To Supply Hydroxychloroquine, Other Medicines To Nepal And Bhutan
Amid Coronavirus Pandemic, Government Bans Export of Anti-Malarial Drug Hydroxychloroquine
IIT Mandi Team Finds Target Protein For Action Of Antimalarial Drug Against Zika Virus
